Lixin Rui - Search Results

Year	Number of Results
2003	2
2005	1
2006	2
2007	2
2010	1
2011	2
2013	1
2014	1
2015	3
2016	4
2017	6
2018	2
2019	5
2020	2
2021	4
2023	3
2024	2

1

DNA methyltransferases in hematological malignancies.

Hoang NM, Rui L. Hoang NM, et al. Among authors: rui l. J Genet Genomics. 2020 Jul 20;47(7):361-372. doi: 10.1016/j.jgg.2020.04.006. Epub 2020 Jul 24. J Genet Genomics. 2020. PMID: 32994141 Free PMC article. Review.

2

EGR1-mediated metabolic reprogramming to oxidative phosphorylation contributes to ibrutinib resistance in B-cell lymphoma.

Liu Y, Kimpara S, Hoang NM, Daenthanasanmak A, Li Y, Lu L, Ngo VN, Bates PD, Song L, Gao X, Bebel S, Chen M, Chen R, Zhang X, Selberg PE, Kenkre VP, Waldmann TA, Capitini CM, Rui L. Liu Y, et al. Among authors: rui l. Blood. 2023 Nov 30;142(22):1879-1894. doi: 10.1182/blood.2023020142. Blood. 2023. PMID: 37738652

3

STAT3 Activation and Oncogenesis in Lymphoma.

Zhu F, Wang KB, Rui L. Zhu F, et al. Among authors: rui l. Cancers (Basel). 2019 Dec 19;12(1):19. doi: 10.3390/cancers12010019. Cancers (Basel). 2019. PMID: 31861597 Free PMC article. Review.

4

PRMT5 in gene regulation and hematologic malignancies.

Zhu F, Rui L. Zhu F, et al. Among authors: rui l. Genes Dis. 2019 Jun 19;6(3):247-257. doi: 10.1016/j.gendis.2019.06.002. eCollection 2019 Sep. Genes Dis. 2019. PMID: 32042864 Free PMC article. Review.

5

BAF155 methylation drives metastasis by hijacking super-enhancers and subverting anti-tumor immunity.

Kim EJ, Liu P, Zhang S, Donahue K, Wang Y, Schehr JL, Wolfe SK, Dickerson A, Lu L, Rui L, Zhong X, Wisinski KB, Yu M, Suzuki A, Lang JM, Ong IM, Xu W. Kim EJ, et al. Among authors: rui l. Nucleic Acids Res. 2021 Dec 2;49(21):12211-12233. doi: 10.1093/nar/gkab1122. Nucleic Acids Res. 2021. PMID: 34865122 Free PMC article.

6

HiJAKing the epigenome in leukemia and lymphoma.

Drennan AC, Rui L. Drennan AC, et al. Among authors: rui l. Leuk Lymphoma. 2017 Nov;58(11):2540-2547. doi: 10.1080/10428194.2017.1312370. Epub 2017 Apr 12. Leuk Lymphoma. 2017. PMID: 28402164 Free PMC article. Review.

7

Malignant pirates of the immune system.

Rui L, Schmitz R, Ceribelli M, Staudt LM. Rui L, et al. Nat Immunol. 2011 Sep 20;12(10):933-40. doi: 10.1038/ni.2094. Nat Immunol. 2011. PMID: 21934679 Review.

8

Hypomethylating agent decitabine sensitizes diffuse large B-cell lymphoma to venetoclax.

Zhu F, Crombie JL, Ni W, Hoang NM, Garg S, Hackett L, Chong SJF, Collins MC, Rui L, Griffin J, Davids MS. Zhu F, et al. Among authors: rui l. Haematologica. 2024 Jan 1;109(1):186-199. doi: 10.3324/haematol.2023.283245. Haematologica. 2024. PMID: 37534528 Free PMC article.

9

Combinatorial fedratinib and venetoclax treatment is effective on human B cell acute lymphoblastic leukemia with high Flt3 expression.

Rinella SP, Bell HC, Turicek DP, Shi L, Hoang NM, Rui L, Hess NJ, Capitini CM. Rinella SP, et al. Among authors: rui l. bioRxiv [Preprint]. 2023 Jun 9:2023.06.07.544058. doi: 10.1101/2023.06.07.544058. bioRxiv. 2023. PMID: 37333339 Free PMC article. Preprint.

10

Lymphoma: current status of clinical and preclinical imaging with radiolabeled antibodies.

England CG, Rui L, Cai W. England CG, et al. Among authors: rui l. Eur J Nucl Med Mol Imaging. 2017 Mar;44(3):517-532. doi: 10.1007/s00259-016-3560-9. Epub 2016 Nov 14. Eur J Nucl Med Mol Imaging. 2017. PMID: 27844106 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

38 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Results by year